KC-5781

MDA-MB-468-B7H4-KO Cell Line

×
Please enable JavaScript in your browser to complete this form.
59042
Home » MDA-MB-468-B7H4-KO Cell Line

Background of MDA-MB-468-B7H4-KO Cell Line

The coinhibitory molecule B7-H4, an important member of the B7 family, is abnormally expressed in tumors, inflammation and autoimmune diseases. B7-H4 negatively regulates T cell immune response and promotes immune escape by inhibiting the proliferation, cytokine secretion, and cell cycle of T cells. Moreover, B7-H4 plays an extremely important role in tumorigenesis and tumor development including cell proliferation, invasion, metastasis, anti-apoptosis, etc. In addition, B7-H4 has the other biological functions, such as protection against type 1 diabetes (T1D) and islet cell transplantation. Therefore, B7-H4 has been identified as a novel marker or a therapeutic target for the treatment of tumors, inflammation, autoimmune diseases, and organ transplantation.

Specifications

Catalog NumberKC-5781
Cell Line NameMDA-MB-468-B7H4-KO Cell Line
Clone Number1A2
Host Cell LineMDA-MB-468
DescriptionStable MDA-MB-468 clone with human B7H4 gene knockout, No.1A2
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10% FBS
Selection MarkerNA
MorphologyEpithelial
SubcultureSplit saturated culture 1:2-1:3 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30-40 hours
Mycoplasma StatusNegative

Cell Line Generation

MDA-MB-468-B7H4-KO cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of MDA-MB-468-B7H4-KO cell line stable clone using PCR sequencing.

Figure 2: Characterization of MDA-MB-468-B7H4-KO cell line stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (DMEM + 10% FBS) in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:2-1:3 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Wang JY, Wang WP. B7-H4, a promising target for immunotherapy. Cell Immunol.2020 Jan;347:104008. doi: 10.1016/j.cellimm.2019.104008. Epub 2019 Nov 4. PMID:31733822.
Please enable JavaScript in your browser to complete this form.